Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Foghorn Therapeutics (FHTX) Return on Invested Capital (2023 - 2024)

Historic Return on Invested Capital for Foghorn Therapeutics (FHTX) over the last 2 years, with Q3 2024 value amounting to 5.0%.

  • Foghorn Therapeutics' Return on Invested Capital rose 28100.0% to 5.0% in Q3 2024 from the same period last year, while for Sep 2024 it was 5.0%, marking a year-over-year increase of 28100.0%. This contributed to the annual value of 2.93% for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q3 2024, Foghorn Therapeutics' Return on Invested Capital is 5.0%, which was up 28100.0% from 1.8% recorded in Q2 2024.
  • Foghorn Therapeutics' Return on Invested Capital's 5-year high stood at 10.07% during Q1 2023, with a 5-year trough of 1.23% in Q1 2024.